Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo

By Egerod F. L.   Nielsen H. S.   Iversen L.   Thorup I.   Storgaard T.   Oleksiewicz M. B.  

Biomarkers, Vol. 10, Iss. 4, 2005-07 ,pp. : 295-309

Informa Healthcare

Access to resources Recommend Favorite

PPAR-γ receptor agonists—a review of their role in diabetic management in Trinidad and Tobago

By Smith Steve Ian  

Molecular and Cellular Biochemistry, Vol. 263, Iss. 1, 2004-08 ,pp. : 189-210

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacophore identification and 3D-QSAR studies in N-(2-benzoyl phenyl)-l-tyrosines as PPAR agonists

By Rathi L.   Kashaw S.K.   Dixit A.   Pandey G.   Saxena A.K.  

Bioorganic and Medicinal Chemistry, Vol. 12, Iss. 1, 2004-01 ,pp. : 63-69

Elsevier

Access to resources Recommend Favorite

Differences in the metabolism and pharmacokinetics of two structurally similar PPAR agonists in dogs: involvement of taurine conjugation

By Kim M.-S.   Shen Z.   Kochansky C.   Lynn K.   Wang S.   Wang Z.   Hora D.   Brunner J.   Franklin R. B.   Vincent S. H.  

Xenobiotica, Vol. 34, Iss. 7, 2004-07 ,pp. : 665-674

Informa Healthcare

Access to resources Recommend Favorite

Modulation of rat liver citochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods

By Espinosa-Aguirre J.J.  

Mutagenesis, Vol. 18, Iss. 1, 2003-01 ,pp. : 95-100

Oxford University Press

Access to resources Recommend Favorite